Gary Owens, MD, president of Gary Owens Associates, addresses how payers can improve outcomes for persons who have pulmonary arterial hypertension (PAH).
Gary Owens, MD, president of Gary Owens Associates, talks next steps payers can take to improve outcomes among persons living with pulmonary arterial hypertension (PAH), including stepping up education effort and improving medication access.
Transcript
What can payers do to make progress against PAH?
This is a disease that is often misunderstood, underrecognized, and underdiagnosed. Hence, that 2- to 3-year journey from symptom onset. So I think payers can hopefully play a role here, too, by helping educate the community. Now, the problem is, trying to get this message across to primary care physicians who are very, very busy with many other things, including the COVID-19 pandemic.
It’s easily possible for a disease that affects 5 to 10 per 1 million to get lost in the shuffle. But I think what it really does say, when these patients are identified by payers, getting case managers involved, and getting those case managers to coordinate that team approach I talked about, as well as making sure that patients have access to the proper pharmaceutical care, is what payers could and should be doing. Not only now but going forward.
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More